Press Releases

With an unwavering commitment to transforming lives, Fresh Start Surgical Gifts is excited to announce a groundbreaking partnership with UMass Memorial Health (UMMH) in Worcester, MA. This collaboration brings Fresh Start's life-changing reconstructive surgeries to the East Coast for the first time, offering vital services and medical care to underprivileged youth at no cost. Treatment for pediatric patients who require dental and orthodontic care due to their craniofacial diagnosis will

Distalmotion’s Dexter Surgical Robot opens an entire new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients. ​​​Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult inguinal hernia repair.  This significant milestone marks another step forward in Distalmotion’s mission to empower robotic surgery

MicroPort ®  MedBot™ (HKSE:2252) announced today that the company successfully completed 6 robot-assisted laparoscopic radical prostatectomy procedures in the Republic of Angola. The surgical cases were performed by Dr. Vipul Patel, a worldrenowned robotic urologist surgeon for his contributions to the field of robotic-assisted surgery and one of the most experienced robotic surgeons in the world having personally performed over 18,000 robotic prostatectomies, and his surgical

Takeda and Boston Medical Center (BMC) today announced a new collaboration focused on identifying innovative solutions that can reduce hard-to-abate greenhouse gas (GHG) emissions in the health care sector. The collaboration between Takeda and BMC aims to reduce the GHG emissions caused by disposal of regulated medical waste, such as pharmaceutical packaging and single-use plastics, which are among the most difficult environmental challenges facing the industry. The effort will also seek

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced impressive three-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt in selected heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction. The results were published in The American Heart Journal. REDUCE LAP-HF II is the world's first phase III trial to eval

CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans, announced it has signed definitive agreements for a strategic investment from Patient Square Capital (Patient Square), a dedicated health care investment firm. Current shareholders, including investment funds affiliated with global investment firm Carlyle (NASDAQ: CG), TT Capital Partners, Sanaka Group, and CorroHealth management, will remain investors, with Patient Square and Carly

NextGen Healthcare, a leading provider of innovative healthcare technology solutions, and OSIS, a non-profit technology services organization, today announced an enhanced premier strategic partnership to help Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs) optimize technology for better patient outcomes and efficient government compliance. OSIS adopted NextGen Healthcare as its Electronic Health Record (EHR) vendor of choice in 2007. As one of NextGen

BrainSpec, the comprehensive software platform enabling virtual biopsies of the brain, has released findings from recent research studies that expand the historic focus on quantitative imaging. 65 individuals with a history of traumatic brain injuries (TBI) participated in this research to investigate the frequency of abnormal findings in the brain using various FDA-cleared image processing tools and programs. Among advanced neuroimaging techniques, such as Magnetic Resonance Spectroscopy (MR

Quest Diagnostics, a leading provider of diagnostic information services, today announced that it has been awarded several contracts by the U.S. Centers for Disease Control and Prevention (CDC) to support testing and sustained laboratory readiness for two emerging infectious diseases recently identified in people in the Americas. The agreements will support the nation's preparedness for avian influenza and Oropouche viruses by ensuring a national commercial laboratory provider i

Medivan and Modivcare have joined forces to address a crucial need in Central California: improving access to essential healthcare services in underserved areas. This partnership, launched in June 2023, is driven by a shared mission to bring reliable, high-quality transportation services to communities that have historically faced challenges in accessing healthcare. A Shared Vision The partnership with Medivan represents more than just an expansion of serv